AQW 17173/17-22


Mr Stewart Dickson
Alliance Party
East Antrim


Tabled Date: 13/04/2021
Answered On Date: 18/05/2021
Priority Written: No


Question:
To ask the Minister of Health how five-year and ten-year survival rates in Northern Ireland, for each type of cancer, compare to other parts of the United Kingdom, and the Republic of Ireland.


Answer:
At present the Northern Ireland Cancer Registry (NICR) have not carried out ten-year survival analysis on any type of cancer. It does however routinely carry out five-year survival analysis on many of the cancer sites. This analysis was part of an international study led by the EUROCARE-5 project investigating survival of cancer patients diagnosed in 2000-2007 with residence in Europe. This survival information, and a UK and Republic of Ireland comparison, is detailed in Table 1 below for 25 major cancer sites.
Northern Ireland
England
Scotland
Wales
Republic of Ireland
Site
RSC
LB
UB
RSC
LB
UB
RSC
LB
UB
RSC
LB
UB
RSC
LB
UB
Head and Neck
48.96
44.36
54.03
46.11
45.33
46.91
43.05
41.08
45.11
42.70
39.79
45.82
42.09
39.01
45.42
Esophagus
16.12 *
13.73
18.92
12.37
11.97
12.79
10.99
9.97
12.13
13.13
11.66
14.79
15.55 *
13.88
17.43
Stomach
18.06
15.89
20.52
17.00
16.57
17.44
16.11
14.96
17.35
17.78
16.21
19.50
20.32
18.72
22.05
Colorectal
54.00
52.50
55.54
52.08
51.80
52.35
53.84
53.03
54.66
50.95
49.91
52.03
54.32
53.29
55.37
Colon
54.25
52.36
56.21
51.34
50.98
51.70
53.88
52.86
54.91
49.94
48.59
51.33
54.97
53.66
56.31
Rectum
54.32
51.85
56.90
53.74
53.30
54.17
54.19
52.86
55.56
52.61
50.94
54.33
53.01
51.36
54.72
Liver
8.87
5.89
13.36
8.24
7.71
8.81
7.40
6.08
9.00
8.71
6.72
11.30
12.99
10.53
16.02
Pancreas
3.02
1.84
4.96
4.67
4.37
4.98
3.44
2.76
4.30
5.37
4.31
6.69
6.88
5.76
8.22
Lung
11.04
10.03
12.16
8.80
8.63
8.98
8.65
8.22
9.11
8.55
7.91
9.24
11.82
11.10
12.59
Soft Tissue
58.40
51.85
65.76
57.63
56.39
58.90
56.39
52.62
60.43
60.20
55.74
65.02
62.70
58.19
67.55
Skin Melanoma
90.74
88.46
93.08
85.35
84.93
85.77
88.82
87.58
90.08
80.05
78.24
81.89
86.44
84.88
88.03
Breast
82.12
80.55
83.71
79.30
79.06
79.55
78.46
77.65
79.28
78.20
77.21
79.20
79.01
77.87
80.16
Cervix Uteri
61.13
56.34
66.32
59.59
58.72
60.47
57.89
55.45
60.44
58.10
55.00
61.38
58.87
55.75
62.16
Corpus Uteri
73.58
69.96
77.38
75.72
75.12
76.32
76.87
74.85
78.95
73.65
71.38
76.00
74.16
71.35
77.09
Ovary
32.27
29.37
35.45
30.57
30.05
31.11
34.02
32.51
35.60
31.66
29.71
33.74
30.34
28.35
32.46
Prostate
83.33
81.48
85.23
80.26
79.95
80.58
78.83
77.74
79.94
78.03
76.87
79.22
85.50
84.47
86.54
Testis
89.11
87.01
91.26
91.81
90.19
93.46
91.61
87.17
96.28
88.31
82.70
94.31
-
-
-
Urinary Bladder
76.13
73.81
78.52
72.34
71.97
72.71
48.98
47.10
50.94
71.67
70.22
73.16
73.40
71.51
75.33
Kidney
48.56
45.28
52.08
47.32
46.74
47.90
46.08
44.42
47.81
49.80
47.64
52.06
51.75
49.43
54.18
Thyroid
79.89
74.62
85.53
81.06
80.11
82.03
81.59
78.58
84.70
76.90
73.16
80.83
75.29
71.22
79.60
Plasma cell
42.30
38.28
46.75
35.41
34.64
36.19
36.62
34.27
39.12
36.69
33.86
39.76
36.15
33.31
39.24
Hodgkin's lymphoma
80.08
75.35
85.11
79.13
78.27
80.00
80.89
78.35
83.51
77.01
73.43
80.76
83.09
79.91
86.39
Non Hodgkin lymphoma
58.99
56.50
61.59
56.73
56.30
57.15
60.34
59.00
61.70
56.61
54.97
58.30
63.04
61.37
64.76
SBLL/CLL
61.53
55.53
68.19
68.83
67.96
69.72
75.66
72.91
78.50
67.19
64.05
70.49
75.69
72.68
78.82
CML
47.99
38.74
59.45
49.57
47.61
51.61
64.62
58.38
71.52
51.91
44.78
60.17
57.94
49.47
67.84
All Sites
51.01
50.47
51.56
50.20
50.11
50.29
46.62
46.35
46.90
49.94
49.58
50.29
53.95
53.57
54.32
Table 1. Age-standardised five-year Relative Survival (RSC %) for patients diagnosed in 2000-2007 for 25 major malignant cancers, by Regions of the UK and Republic of Ireland with corresponding 95% Confidence Intervals.
Source: Northern Ireland Cancer Registry (NICR)
Relative Survival Cumulative (RSC), Lower Bound 95% Confidence Interval (LB), Upper Bound 95% Confidence Interval (UB)
* Age standardised survival value is unexpectedly high compared to the European mean for this rapidly fatal cancer. This can be due to several reasons including: i) random variations and instability in one or more age classes; ii) problems in the follow up ascertainment; iii) problems in capturing all incident cases, particularly those with worse prognosis, or difficulties in accessing death certificates or in tracing back cases known by death certificate only.